ECA
Elevated Capital Advisors’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Hold |
1,833
| – | – | 0.42% | 53 |
|
|
2025
Q1 | $1.51M | Sell |
1,833
-189
| -9% | -$156K | 0.42% | 53 |
|
|
2024
Q4 | $1.56M | Buy |
2,022
+658
| +48% | +$508K | 0.43% | 51 |
|
|
2024
Q3 | $1.21M | Buy |
1,364
+235
| +21% | +$208K | 0.32% | 81 |
|
|
2024
Q2 | $1.02M | Buy |
1,129
+69
| +7% | +$62.5K | 0.29% | 88 |
|
|
2024
Q1 | $825K | Sell |
1,060
-19
| -2% | -$14.8K | 0.24% | 104 |
|
|
2023
Q4 | $629K | Buy |
1,079
+19
| +2% | +$11.1K | 0.2% | 119 |
|
|
2023
Q3 | $569K | Sell |
1,060
-57
| -5% | -$30.6K | 0.19% | 115 |
|
|
2023
Q2 | $524K | Buy |
1,117
+59
| +6% | +$27.7K | 0.17% | 129 |
|
|
2023
Q1 | $363K | Buy |
1,058
+60
| +6% | +$20.6K | 0.13% | 140 |
|
|
2022
Q4 | $365K | Buy |
+998
| New | +$365K | 0.14% | 130 |
|